{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:37:54Z","timestamp":1790534274829,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.purol.2014.11.004","type":"journal-article","created":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T08:09:33Z","timestamp":1416298173000},"page":"188-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Place des biomarqueurs urinaires dans le diagnostic et le suivi des troubles du bas appareil urinaire\u00a0: une revue de la litt\u00e9rature"],"prefix":"10.1016","volume":"25","author":[{"given":"B.","family":"Peyronnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bendavid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Manunta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Damphousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cheensse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Brochard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Castel-Lacanal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Siproudhis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Bensalah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Gam\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.purol.2014.11.004_bib0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000013449","article-title":"Observations on the Liber medicine orinalibus by Hermogenes","volume":"19","author":"Iorio","year":"1999","journal-title":"Am J Nephrol."},{"key":"10.1016\/j.purol.2014.11.004_bib0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.purol.2014.11.004_bib0015","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1074\/mcp.R600004-MCP200","article-title":"Discovery of urinary biomarkers","volume":"5","author":"Pisitkun","year":"2006","journal-title":"Mol Cell Proteomics"},{"issue":"5","key":"10.1016\/j.purol.2014.11.004_bib0020","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.bbapap.2013.06.016","article-title":"Urine as a source for clinical proteome analysis: from discovery to clinical application","volume":"1844","author":"Rodr\u00edguez-Su\u00e1rez","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"10.1016\/j.purol.2014.11.004_bib0025","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.purol.2012.08.004","article-title":"\u00c9tude compar\u00e9e des recommandations publi\u00e9es sur l\u2019incontinence urinaire f\u00e9minine","volume":"22","author":"Hermieu","year":"2012","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2014.11.004_bib0030","article-title":"EAU Guidelines on neurogenic lower urinary tract dysfunction","author":"Pannek","year":"2014","journal-title":"Uroweb"},{"issue":"6","key":"10.1016\/j.purol.2014.11.004_bib0035","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/S0022-5347(17)39761-6","article-title":"The value of leak pressure and bladder compliance in the urodynamic evaluation of meningomyelocele patients","volume":"144","author":"Ghoniem","year":"1990","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.purol.2014.11.004_bib0040","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1166-7087(07)92379-9","article-title":"Recommandations du groupe d\u2019\u00e9tude de neuro-urologie de langue fran\u00e7aise pour le suivi du bless\u00e9 m\u00e9dullaire et du patient spina bifida","volume":"17","author":"Ruffion","year":"2007","journal-title":"Prog Urol"},{"issue":"1","key":"10.1016\/j.purol.2014.11.004_bib0045","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-5347(01)64054-0","article-title":"Morbidity of the evaluation of the lower urinary tract with transurethral multichannel pressure-flow studies","volume":"159","author":"Klingler","year":"1998","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.purol.2014.11.004_bib0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0302-2838(02)00494-3","article-title":"Are urodynamic tests useful tools for the initial conservative management of non-neurogenic urinary incontinence?. A review of the literature","volume":"43","author":"Colli","year":"2003","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.purol.2014.11.004_bib0055","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/nau.21155","article-title":"Non-invasive techniques in the diagnosis of bladder storage disorders","volume":"30","author":"Farag","year":"2011","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"10.1016\/j.purol.2014.11.004_bib0060","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.juro.2009.05.001","article-title":"Proteomics and opportunities for clinical translation in urological disease","volume":"182","author":"Vaezzadeh","year":"2009","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.purol.2014.11.004_bib0065","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11427-011-4162-1","article-title":"Applications of urinary proteomics in biomarker discovery","volume":"54","author":"Shao","year":"2011","journal-title":"Sci China Life Sci"},{"issue":"10","key":"10.1016\/j.purol.2014.11.004_bib0070","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1074\/mcp.R800001-MCP200","article-title":"Urine in clinical proteomics","volume":"7","author":"Decramer","year":"2008","journal-title":"Mol Cell Proteomics"},{"issue":"Suppl 3","key":"10.1016\/j.purol.2014.11.004_bib0075","first-page":"S6","article-title":"Chapter 2: Pathophysiology of neurogenic detrusor overactivity and the symptom complex of \u201cOveractive bladder\u201d","volume":"33","author":"Chapple","year":"2014","journal-title":"Neurourol Urodyn"},{"issue":"10","key":"10.1016\/j.purol.2014.11.004_bib0080","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1442-2042.2005.01140.x","article-title":"Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom","volume":"12","author":"Kim","year":"2005","journal-title":"Int J Urol"},{"issue":"5","key":"10.1016\/j.purol.2014.11.004_bib0085","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0022-5347(05)00992-4","article-title":"Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder","volume":"175","author":"Kim","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.11.004_bib0090","first-page":"1227","volume":"30","author":"Ochodnicky","year":"2011","journal-title":"Nerve Growth Factor in bladder dysfunction: contributing factor, biomarker and therapeutic target NeuroUrol Urodyn"},{"key":"10.1016\/j.purol.2014.11.004_bib0095","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1172\/JCI115488","article-title":"Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function","volume":"88","author":"Steers","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.purol.2014.11.004_bib0100","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0090-4295(00)00886-4","article-title":"Changes in detrusor and urinary growth factors according to detrusor function after partial bladder outlet obstruction in the rat","volume":"57","author":"Kim","year":"2001","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.purol.2014.11.004_bib0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/nau.22438","article-title":"Neurotrophins in bladder function: what do we know and where do we go from here?","volume":"33","author":"Cruz","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.purol.2014.11.004_bib0110","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00192-012-2027-1","article-title":"Biomarkers in overactive bladder","volume":"24","author":"Bide","year":"2013","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.purol.2014.11.004_bib0115","first-page":"2014","article-title":"What is the role for biomarkers for lower urinary tract disorders? ICI-RS","author":"Fry","year":"2013","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"10.1016\/j.purol.2014.11.004_bib0120","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11255-009-9647-5","article-title":"Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study","volume":"42","author":"Tyagi","year":"2010","journal-title":"Int Urol Nephrol"},{"issue":"5.","key":"10.1016\/j.purol.2014.11.004_bib0125","article-title":"Urinary ATP may be a dynamic biomarker of detrusor overactivity in women with overactive bladder syndrome","volume":"8","author":"Silva-Ramos","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.purol.2014.11.004_bib0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"issue":"6 Suppl.","key":"10.1016\/j.purol.2014.11.004_bib0135","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.juro.2012.09.079","article-title":"Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline","volume":"188","author":"Gormley","year":"2012","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.purol.2014.11.004_bib0140","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/nau.20519","article-title":"Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder","volume":"27","author":"Yokoyama","year":"2008","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"10.1016\/j.purol.2014.11.004_bib0145","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/j.juro.2008.01.146","article-title":"Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder","volume":"179","author":"Liu","year":"2008","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.purol.2014.11.004_bib0150","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.eururo.2008.04.037","article-title":"Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection","volume":"56","author":"Liu","year":"2009","journal-title":"Eur Urol"},{"issue":"10","key":"10.1016\/j.purol.2014.11.004_bib0155","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1464-410X.2008.07757.x","article-title":"Urinary nerve growth factor level could be a biomarker in the differential diagnosis of mixed urinary incontinence in women","volume":"102","author":"Liu","year":"2008","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.purol.2014.11.004_bib0160","first-page":"4989","article-title":"Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients","volume":"17","author":"Jacobs","year":"2010","journal-title":"Can J Urol"},{"issue":"5","key":"10.1016\/j.purol.2014.11.004_bib0165","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1464-410X.2010.09585.x","article-title":"Urinary nerve growth factor in women with overactive bladder syndrome","volume":"107","author":"Liu","year":"2011","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.purol.2014.11.004_bib0170","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jpurol.2012.06.003","article-title":"Urinary nerve growth factor in children with overactive bladder: a promising, noninvasive and objective biomarker","volume":"9","author":"Oktar","year":"2013","journal-title":"J Pediatr Urols"},{"issue":"1","key":"10.1016\/j.purol.2014.11.004_bib0175","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.juro.2012.08.187","article-title":"Urinary neurotrophic factors in healthy individuals and patients with overactive bladder","volume":"189","author":"Antunes-Lopes","year":"2013","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.purol.2014.11.004_bib0180","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00192-012-1854-4","article-title":"Changes in urinary nerve growth factor and prostaglandin E2 in women with overactive bladder after anticholinergics","volume":"24","author":"Cho","year":"2013","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.purol.2014.11.004_bib0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.07.007","article-title":"Sacral nerve stimulation reduces elevated urinary nerve growth factor levels in women with symptomatic detrusor overactivity","author":"Shalom","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.purol.2014.11.004_bib0190","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11255-013-0540-x","article-title":"Urinary brain-derived neurotrophic factor: a potential biomarker for objective diagnosis of overactive bladder","volume":"46","author":"Wang","year":"2014","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"10.1016\/j.purol.2014.11.004_bib0195","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.juro.2014.02.091","article-title":"Overactive bladder changes with time: a 5-year longitudinal followup of changes in overactive bladder symptoms, urodynamic studies and urinary nerve growth factor levels","volume":"192","author":"Chuang","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.11.004_bib0200","doi-asserted-by":"crossref","DOI":"10.1007\/s00192-014-2424-8","article-title":"Urinary nerve growth factor correlates with the severity of urgency and pain","author":"Kim","year":"2014","journal-title":"Int Urogynecol J"},{"issue":"6","key":"10.1016\/j.purol.2014.11.004_bib0205","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2220\/biomedres.30.343","article-title":"A higher level of prostaglandin E2 in the urinary bladder in young boys and boys with lower urinary tract obstruction","volume":"30","author":"Aoki","year":"2009","journal-title":"Biomed Res"},{"issue":"11","key":"10.1016\/j.purol.2014.11.004_bib0210","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1464-410X.2009.08851.x","article-title":"Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis\/bladder pain syndrome and detrusor overactivity","volume":"106","author":"Liu","year":"2010","journal-title":"BJU Int"},{"issue":"8","key":"10.1016\/j.purol.2014.11.004_bib0215","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00192-011-1401-8","article-title":"Differential profile analysis of urinary cytokines in patients with overactive bladder","volume":"22","author":"Ghoniem","year":"2011","journal-title":"Int Urogynecol J"},{"issue":"5","key":"10.1016\/j.purol.2014.11.004_bib0220","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2220\/biomedres.30.287","article-title":"Relationship between lower urinary tract symptoms and urinary ATP in patients with benign prostatic hyperplasia or overactive bladder","volume":"30","author":"Sugaya","year":"2009","journal-title":"Biomed Res"},{"issue":"8","key":"10.1016\/j.purol.2014.11.004_bib0225","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/jamainternmed.2013.4074","article-title":"Biomarkers in cardiovascular medicine: the shame of publication bias","volume":"173","author":"Nissen","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.purol.2014.11.004_bib0230","doi-asserted-by":"crossref","first-page":"1267.e13-9","DOI":"10.1016\/j.urology.2010.06.012","article-title":"Urinary prostaglandin E2 was increased in patients with suprapontine brain diseases, and associated with overactive bladder syndrome","volume":"76","author":"Yamauchi","year":"2010","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.purol.2014.11.004_bib0235","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/00365599.2012.752402","article-title":"Urinary nerve growth factor level in children with neurogenic bladder due to myelomeningocele","volume":"47","author":"Korzeniecka-Kozerska","year":"2013","journal-title":"Scand J Urol"},{"issue":"1","key":"10.1016\/j.purol.2014.11.004_bib0240","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.08.025","article-title":"TGF-\u03b21, TIMP-2 and bladder wall thickness predict neurourological findings in children with myelodysplasia","volume":"191","author":"Sekerci","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.11.004_bib0245","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1464-410X.2009.08533.x","article-title":"Urinary nerve growth factor level is correlated with the severity of neurological impairment in patients with cerebrovascular accident","volume":"104","author":"Liu","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2014.11.004_bib0250","article-title":"EAU Guidelines on chronic pelvic pain","author":"Engeler","year":"2014","journal-title":"Uroweb"},{"issue":"Suppl. 1","key":"10.1016\/j.purol.2014.11.004_bib0255","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/iju.12311","article-title":"Potential urine and serum biomarkers for patients with bladder pain syndrome\/interstitial cystitis","volume":"21","author":"Kuo","year":"2014","journal-title":"Int J Urol"},{"issue":"12","key":"10.1016\/j.purol.2014.11.004_bib0260","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.purol.2010.09.011","article-title":"Algorithmes diagnostiques des douleurs pelvi-p\u00e9rinales chroniques: des sympt\u00f4mes aux syndromes","volume":"20","author":"Rigaud","year":"2010","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2014.11.004_bib0265","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1113595","article-title":"A randomized trial of urodynamic testing before stress-incontinence surgery","volume":"316","author":"Nager","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.purol.2014.11.004_bib0270","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.juro.2011.03.105","article-title":"Baseline urodynamic predictors of treatment failure 1 year after mid urethral sling surgery","volume":"186","author":"Nager","year":"2011","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.purol.2014.11.004_bib0275","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.juro.2013.10.051","article-title":"Inflammatory and tissue remodeling urinary biomarkers before and after mid urethral sling surgery for stress urinary incontinence","volume":"191","author":"Chai","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.11.004_bib0280","doi-asserted-by":"crossref","DOI":"10.1111\/iju.12570","article-title":"Decreased urinary nerve growth factor reflects prostatic volume reduction and relief of outlet obstruction in patients with benign prostatic enlargement treated with dutasteride","author":"Wada","year":"2014","journal-title":"Int J Urol"},{"issue":"1","key":"10.1016\/j.purol.2014.11.004_bib0285","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.urology.2008.01.069","article-title":"Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment","volume":"72","author":"Liu","year":"2008","journal-title":"Urology"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708714006599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708714006599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:26:00Z","timestamp":1761114360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708714006599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1166708714006599"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2014.11.004","relation":{},"ISSN":["1166-7087"],"issn-type":[{"value":"1166-7087","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Place des biomarqueurs urinaires dans le diagnostic et le suivi des troubles du bas appareil urinaire\u00a0: une revue de la litt\u00e9rature","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2014.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}